Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Filings indexed 790 across all filing types
Latest filing 2025-01-28 Regulatory Filings
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-28 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board of Directors meeting scheduled to consider and approve the company's quarterly financial results. It references Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain any financial data or results itself, but rather is an announcement of the meeting where such results will be approved. The document length is only 1694 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about an upcoming event and not the financial report itself or a detailed management discussion.
2025-01-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a short notice informing the stock exchanges about the schedule of an analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and explicitly states that no unpublished price sensitive information will be shared. The document is brief (1671 characters) and serves as an announcement of a meeting rather than a detailed report or transcript. It does not contain financial data, management discussion, or detailed presentation content. Therefore, it fits best under the category of Investor Presentation announcements or meeting schedule notifications. Given the options, the closest and most appropriate classification is 'Investor Presentation' (IP), as it relates to investor meetings and presentations, even though the document itself is a meeting schedule notice rather than the presentation content. Confidence is high due to clear regulatory reference and document purpose.
2025-01-16 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement (2522 characters) addressed to stock exchanges (NSE and BSE) about the inauguration of a new Tissue & Bone Bank by Shalby Limited. It contains no financial data, no regulatory filings, no voting results, no management or board changes, no earnings or financial statements. It is a corporate event announcement related to healthcare infrastructure expansion. The document does not fit into any financial report category such as Annual Report, Interim Report, Earnings Release, or Capital Update. It is not a regulatory filing or certification either. Given the content and length, it is best classified as a Regulatory Filing (RNS) as a general announcement to the stock exchanges that does not fit other categories.
2025-01-16 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shalby Limited informing the stock exchanges about FDA approval received by its subsidiary for a medical device. It is addressed to the listing departments of NSE and BSE and requests them to take the information on record. There is no financial data, no detailed report, no management discussion, or regulatory filing content beyond this announcement. The document length is only 1290 characters, which is very short and clearly an announcement rather than a full report. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings that require substantive content. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2025-01-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialized/rematerialized securities details submitted to stock exchanges. The document is short (3157 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is primarily a regulatory filing confirming compliance with SEBI regulations.
2025-01-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.